---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-25-004754"
form_type: "8-K"
ticker: "BGLC"
cik: "0001737523"
company_name: "BioNexus Gene Lab Corp"
filed_at: "2025-06-23T23:59:59+00:00"
generated_at: "2026-05-18T23:55:38.651755+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# BioNexus Gene Lab appoints Chong Set Fui as CFO effective immediately

## Summary
- Appointed Chong Set Fui (Angeline) as CFO and Principal Financial Officer, effective June 17, 2025.
- Chong has 25+ years senior financial experience, most recently CFO of Avillion Berhad (2013-2024).
- Monthly salary RM15,000 (~$3,500 USD) plus medical, fuel allowance, and discretionary bonus.
- Appointment is for a fixed term from June 17, 2025 to June 16, 2027, renewable with one-month notice.
- Su-Leng Tan Lee ceased as acting CFO concurrently.

## SEC filing metadata
- accession: 0001477932-25-004754
- form_type: 8-K
- ticker: BGLC
- cik: 0001737523
- company_name: BioNexus Gene Lab Corp
- filed_at: 2025-06-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737523/000147793225004754/0001477932-25-004754-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737523/000147793225004754/bglc_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-25-004754
- JSON: https://secwatch.observer/filing/0001477932-25-004754.json
- Plain text: https://secwatch.observer/filing/0001477932-25-004754.txt

## Key facts
- Executive change
  Su-Leng Tan Lee departed as acting Chief Financial Officer and Principal Financial Officer at BioNexus Gene Lab Corp.
  - Action: ceased
  - Role: acting Chief Financial Officer and Principal Financial Officer
  source text: Concurrent with the new appointment, Mr. Su-Leng Tan Lee ceased his role as acting Chief Financial Officer and Principal Financial Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1737523/000147793225004754/0001477932-25-004754-index.htm
- Executive change
  Chong Set Fui (Angeline) was appointed as Chief Financial Officer and Principal Financial Officer at BioNexus Gene Lab Corp.
  - Action: appointed
  - Role: Chief Financial Officer and Principal Financial Officer
  source text: On June 17, 2025, the Board of Directors of BioNexus Gene Lab Corp. (the “Company”) appointed Ms. Chong Set Fui (Angeline) as the Company’s Chief Financial Officer and Principal Financial Officer, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1737523/000147793225004754/0001477932-25-004754-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.